Trial primary completion date • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • PGR (Progesterone receptor) • MUC1 (Mucin 1)
|
HER-2 positive • HR positive • HER-2 negative • HR negative • ER negative • MUC1 expression • HR positive + HER-2 negative
|
huMNC2-CAR22 • huMNC2-CAR44 CAR T cells